{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:34:03Z","timestamp":1790688843316,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":3209,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009467","name":"University of the Witwatersrand, Johannesburg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009467","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.jpainsymman.2010.07.006","type":"journal-article","created":{"date-parts":[[2010,12,9]],"date-time":"2010-12-09T10:21:52Z","timestamp":1291890112000},"page":"700-706","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["HIV Neuropathy Risk Factors and Symptom Characterization in Stavudine-Exposed South Africans"],"prefix":"10.1016","volume":"41","author":[{"given":"Antonia L.","family":"Wadley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine L.","family":"Cherry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Kamerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2010.07.006_bib1","first-page":"889","article-title":"Neuropathic pain in AIDS patients prior to antiretroviral therapy","volume":"98","author":"Hitchcock","year":"2008","journal-title":"S Afr Med J"},{"key":"10.1016\/j.jpainsymman.2010.07.006_bib2","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/01.wco.0000245366.59446.57","article-title":"Recent advances in HIV neuropathy","volume":"19","author":"Cornblath","year":"2006","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.jpainsymman.2010.07.006_bib3","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1212\/WNL.44.10.1892","article-title":"Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985\u20131992","volume":"44","author":"Bacellar","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.jpainsymman.2010.07.006_bib4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1212\/WNL.0b013e3181af7a22","article-title":"Age and height predict neuropathy risk in patients with HIV prescribed stavudine","volume":"73","author":"Cherry","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jpainsymman.2010.07.006_bib5","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1212\/01.wnl.0000203336.12114.09","article-title":"Antiretroviral use and other risks for HIV-associated neuropathies in an international cohort","volume":"66","author":"Cherry","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jpainsymman.2010.07.006_bib6","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1258\/095646207782717054","article-title":"Early detection of subclinical HIV sensory polyneuropathy using intraepidermal nerve fibre density quantification: association with HIV stage and surrogate markers","volume":"18","author":"Skopelitis","year":"2007","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.jpainsymman.2010.07.006_bib7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1468-1293.2007.00478.x","article-title":"Prevalence of and risk factors for HIV-associated neuropathy in Melbourne, Australia 1993-2006","volume":"8","author":"Smyth","year":"2007","journal-title":"HIV Med"},{"key":"10.1016\/j.jpainsymman.2010.07.006_bib8","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/01.qai.0000159668.80207.5b","article-title":"Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana","volume":"40","author":"Wester","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jpainsymman.2010.07.006_bib9","author":"World Health Organization"},{"key":"10.1016\/j.jpainsymman.2010.07.006_bib10","author":"World Health Organization"},{"key":"10.1016\/j.jpainsymman.2010.07.006_bib11","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/QAD.0b013e3283360976","article-title":"The high cost of second-line antiretroviral therapy for HIV\/AIDS in South Africa","volume":"24","author":"Long","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.jpainsymman.2010.07.006_bib12","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/QAI.0b013e31817ae5ef","article-title":"Cost and cost-effectiveness of switching from stavudine to tenofovir in first-line antiretroviral regimens in South Africa","volume":"48","author":"Rosen","year":"2008","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jpainsymman.2010.07.006_bib13","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1212\/01.wnl.0000187119.33075.41","article-title":"Evaluation of a clinical screening tool for HIV-associated sensory neuropathies","volume":"65","author":"Cherry","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jpainsymman.2010.07.006_bib14","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/S0140-6736(04)16508-2","article-title":"Peripheral neuropathy","volume":"363","author":"England","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jpainsymman.2010.07.006_bib15","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1212\/WNL.0b013e3181dd436d","article-title":"Hepatitis C seropositivity is not a risk factor for sensory neuropathy among HIV patients","volume":"74","author":"Cherry","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jpainsymman.2010.07.006_bib16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1212\/01.wnl.0000316390.17248.65","article-title":"Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region","volume":"71","author":"Wright","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jpainsymman.2010.07.006_bib17","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00002030-200002180-00009","article-title":"Incidence of neuropathy in HIV-infected patients on monotherapy versus those on combination therapy with didanosine, stavudine and hydroxyurea","volume":"14","author":"Moore","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.jpainsymman.2010.07.006_bib18","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/ana.20816","article-title":"Sensory neuropathy in human immunodeficiency virus\/acquired immunodeficiency syndrome patients: protease inhibitor-mediated neurotoxicity","volume":"59","author":"Pettersen","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jpainsymman.2010.07.006_bib19","author":"World Health Organization"},{"key":"10.1016\/j.jpainsymman.2010.07.006_bib20","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1517\/14740338.7.3.283","article-title":"Safety of stavudine in the treatment of HIV infection with a special focus on resource-limited settings","volume":"7","author":"Makinson","year":"2008","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jpainsymman.2010.07.006_bib21","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1089\/aid.2008.0045","article-title":"Can we predict neuropathy risk before stavudine prescription in a resource-limited setting?","volume":"24","author":"Affandi","year":"2008","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.jpainsymman.2010.07.006_bib22","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/mus.21465","article-title":"Neuromuscular diseases associated with HIV-1 infection","volume":"40","author":"Robinson-Papp","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jpainsymman.2010.07.006_bib23","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1212\/01.WNL.0000120622.91018.EA","article-title":"Symptomatic distal sensory polyneuropathy in HIV after age 50","volume":"62","author":"Watters","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jpainsymman.2010.07.006_bib24","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1212\/01.wnl.0000264888.87918.a1","article-title":"Correlates of epidermal nerve fiber densities in HIV-associated distal sensory polyneuropathy","volume":"68","author":"Zhou","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jpainsymman.2010.07.006_bib25","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/mus.21535","article-title":"HIV neuropathy in South Africans: frequency, characteristics, and risk factors","volume":"41","author":"Maritz","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jpainsymman.2010.07.006_bib26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/ajpa.20318","article-title":"Effect of ethnicity and sex on the growth of the axial and appendicular skeleton of children living in a developing country","volume":"130","author":"Nyati","year":"2006","journal-title":"Am J Phys Anthropol"},{"key":"10.1016\/j.jpainsymman.2010.07.006_bib27","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1136\/bmj.1.6164.663","article-title":"Drug-induced peripheral neuropathies","volume":"1","author":"Argov","year":"1979","journal-title":"Br Med J"},{"key":"10.1016\/j.jpainsymman.2010.07.006_bib28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1056\/NEJM195607192550304","article-title":"Prophylaxis of isoniazid neuropathy with pyridoxine","volume":"255","author":"Carlson","year":"1956","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpainsymman.2010.07.006_bib29","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/QAI.0b013e318033ffa1","article-title":"Clinical toxicity of highly active antiretroviral therapy in a home-based AIDS care program in rural Uganda","volume":"44","author":"Forna","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"Suppl","key":"10.1016\/j.jpainsymman.2010.07.006_bib30","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1002\/ana.410230723","article-title":"Treatment of the neuromuscular complications of human immunodeficiency virus infection","volume":"23","author":"Cornblath","year":"1988","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jpainsymman.2010.07.006_bib31","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4065\/81.2.213","article-title":"Human immunodeficiency virus-associated peripheral neuropathies","volume":"81","author":"Ferrari","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jpainsymman.2010.07.006_bib32","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1001\/archneur.1988.00520330023005","article-title":"Peripheral neuropathy associated with acquired immunodeficiency syndrome","volume":"45","author":"So","year":"1988","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jpainsymman.2010.07.006_bib33","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0140-6736(06)68580-2","article-title":"Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment","volume":"367","author":"Ferradini","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jpainsymman.2010.07.006_bib34","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1365-3156.2005.01409.x","article-title":"Evaluation of antiretroviral therapy results in a resource-poor setting in Blantyre, Malawi","volume":"10","author":"van Oosterhout","year":"2005","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.jpainsymman.2010.07.006_bib35","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1089\/aid.2007.0168","article-title":"Cytokine genotype suggests a role for inflammation in nucleoside analog-associated sensory neuropathy (NRTI-SN) and predicts an individual\u2019s NRTI-SN risk","volume":"24","author":"Cherry","year":"2008","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.jpainsymman.2010.07.006_bib36","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1097\/01.aids.0000180786.02930.a1","article-title":"Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: an adult AIDS clinical trials group study","volume":"19","author":"Hulgan","year":"2005","journal-title":"AIDS"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392410006962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392410006962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:05:22Z","timestamp":1760130322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392410006962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0885392410006962"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2010.07.006","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIV Neuropathy Risk Factors and Symptom Characterization in Stavudine-Exposed South Africans","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2010.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}